INTRODUCTION
SNPs (single nucleotide polymorphisms) are the most common source of genetic variation in humans, accounting for approx. 90 % of sequence differences [1] [2] [3] [4] [5] [6] . Recent high-throughput genotyping technologies have enabled the measurement of SNP allele frequency differences between case and control populations on a genome-wide scale and have provided a wealth of information on genetic variation in the human population [7] . Public databases describe millions of human SNPs and frequency data for hundreds of thousands of these variants (http://www.ncbi. nlm.nih.gov/SNP/snp_summary.cgi) [2, [8] [9] [10] .
One of the challenges in the analysis of human genetic variation is to distinguish functional from non-functional variants. The most straightforward instances are those in which the variants are both associated with a protein-coding gene and with a genetic disease. These may be synonymous variants, which encode the identical amino acid but regulate splicing or translation, or nonsynonymous variants affecting protein sequence and consequently protein function or stability. Computational analysis of diseasecausing variants predicts that approx. 75 % of the mutations destabilize the protein, and only 7 % directly affect biochemical function, suggesting that change in protein stability is the most common mechanism underlying monogenic disease [11] [12] [13] .
Disease-causing variants comprise the minority of SNPs in the human proteome. The more commonly found protein-associated SNPs have no obvious phenotype. This assertion is based not only on the lack of a phenotypic change, but also from predictions of functional effects using the 3D (three-dimensional) structure of the proteins as a guide (see the review by Teng et al. [14] and also SNPs3D [15] , PolyPhen [16, 17] , TopoSNP [18] , ModSNP [19] , LS-SNP [20] , SNPeffect [21] , MutDB [22] , SNP@Domain [23] , Snap [24] , StSNP [25] and Bongo [26] ). However, although most nsSNPs (non-synonymous SNPs) are thought to have no functional consequences, computational analysis predicts that a significant portion -up to 30 % -are substantially less stable than the most common variant. If even a fraction of these variants did indeed affect protein function, then it is possible that they may contribute to the heterogeneity of the human population. On the other hand, some nsSNPs could affect protein function by affecting protein dynamics without changing protein stability [14] .
To explore the frequency with which nsSNPs affect protein stability and activity, we selected 46 variants of 16 different human proteins for which the 3D structures are known, purified them and screened them for stability by DSLS (differential static light scattering), and where possible we determined their catalytic efficiency. DSLS is an aggregation-based method for assessing protein stability. In this method, the point of inflection of a denaturation curve, termed T agg (aggregation temperature), is determined by detecting scattered light from the denatured and aggregated protein. DSLS and DSF (differential scanning fluorimetry) have been compared extensively and shown to produce similar results for the majority of proteins [27] . However, fluorescent background introduced by some proteins limits the use of DSF, whereas DSLS is not sensitive to protein hydrophobicity [28, 29] . Thermostability of globular proteins can be evaluated and discussed in terms of thermodynamic stability and kinetic stability when the protein denatures reversibly or irreversibly respectively [30] [31] [32] [33] . DSLS is based on the assumption that most proteins denature irreversibly and form aggregates during thermal denaturation. Light scattering as a measure of protein aggregation is a very sensitive technique; however, proteins that reversibly unfold and do not form aggregates are not amenable to this method of analysis [34] . The irreversible denaturation of proteins can be studied in most cases by measuring the rate of thermally induced activity loss at a set temperature, such as 37
• C, similar to in vivo conditions.
Among the selected variants were 21 variants of human cytosolic SULTs (sulfotransferases), which catalyse the transfer of a sulfonate group from PAPS (3 -phosphoadenosine 5 -phosphosulfate) to an acceptor group of substrates including drugs, hormones and xenobiotics [35] [36] [37] [38] [39] [40] [41] [42] [43] . We also included 16 variants of human PKM2 [PK (pyruvate kinase) muscle 2]. PK is a key enzyme in the glycolysis pathway and catalyses the formation of pyruvate and ATP from phosphoenolpyruvate and ADP (see Supplementary Figure S1 at http://www.BiochemJ.org/bj/424/ bj4240015add.htm) [44] . Overall, four PK isoforms are expressed in human, namely PKL, PKR, PKM1 and PKM2. The PKL and PKR isoforms are expressed in liver and erythrocytes respectively, from a single gene by use of different promoters [45] . PKM1 and PKM2 isoforms are produced from the same gene by alternative RNA splicing [46] . PKM2 is found primarily in rapidly proliferating fetal tissues and tumour cells, but is replaced by PKM1 in normal adult tissues such as muscle and brain, for which large amounts of energy are required. This protein is essential for tumour cell growth and metabolism and therefore any change in its availability, level of activity or allosteric regulation may affect tumorigenesis [47] [48] [49] [50] [51] . PKM2 activity is allosterically activated by FBP (fructose 1,6-bisphosphate). A recent report showed that the activity of PKM2 can be regulated by tyrosine kinase signalling pathways via binding to a phosphotyrosinecontaining peptide [50] . Binding of phosphotyrosine peptides to PKM2 results in the release of FBP and subsequent inhibition of enzymatic activity that lead to a build-up of glycolytic intermediates, which in turn can be used for fatty acid and nucleic acid synthesis, promoting proliferation in PKM2-expressing cancer cells. However, once FBP is released, the concentration of FBP at the time determines whether PKM2 goes into a low-activity state or rebinds FBP and is re-activated [50] . In this model, PKM2 only has the ability to undergo dynamic regulation by FBP if a tyrosine kinase pathway is activated (Supplementary Figure S1) . Our results show that a great number of PKM2 SNPs affect protein availability and function. We characterized these PKM2 variants in more detail to understand the effects of human SNPs on allosteric activity of the enzyme, an important characteristic of PKM2 which is critical for tumour cell growth. Our results show that PKM2 S437Y and E28K variants exhibit changes in their allosteric regulation compared with the wild-type enzyme.
MATERIALS AND METHODS

Cloning
All genes were cloned by PCR amplification of cDNA templates of the wild-type genes using Pfu Ultra II (Stratagene). The PCR primers added 15 bp overhangs that were homologous with the ends of BseRI linearized pET28a-LIC. For site-directed mutagenesis, the genes were PCR-amplified as two or more fragments using mutagenic primers which spanned the altered codons and added 20 bp of homologous overhanging sequence between sequential fragments of the genes. PCR products were directionally assembled into pET28a-LIC in a single reaction using the In-Fusion cloning enzyme (Clontech). All genes were cloned into a modified pET vector, pET28a-LIC (GenBank ® EF442785), and all mutations were confirmed by sequencing.
Expression and purification
The SULT wild-type and SNP constructs were transformed into Escherichia coli strain BL21-CodonPlus (DE3)-RIPL (Stratagene; catalogue number 230280), and the cells were grown in 2-8 litres of Terrific Broth at 37
• C with 50 μg/ml kanamycin and 30 μg/ml chloromphenicol to a D 600 of ∼ 1. Protein expression was induced by the addition of 0.5 mM isopropyl β-D-thiogalactoside with shaking overnight at 15
• C. Cells were harvested by centrifugation, resuspended in binding buffer [50 mM Hepes, 500 mM NaCl, 5 mM imidazole and 5 % (v/v) glycerol, pH 7.5] with protease inhibitors (1 mM benzamidine HCl and 1 mM PMSF), frozen in liquid nitrogen, and stored at −80
• C. The thawed cells were lysed by incubation with 22.5 units/ml of benzonase and 0.5 % CHAPS for 30 min at 4
• C, followed by sonication, in the presence of protease inhibitors, at a frequency of 8.5 for three cycles of 10 s on and 10 s off using Sonicator 3000 (Misonix; model S3000-001). The lysate was then clarified by centrifugation, and the supernatant was loaded on a DE52 column (Whatman catalogue number 4057200) preequilibrated with binding buffer. The flow-through was loaded on a Ni-NTA (Ni 2+ -nitrilotriacetate) Superflow column (Qiagen catalogue number 30450) pre-equilibrated with binding buffer. The column was washed with wash buffer (50 mM Hepes, 500 mM NaCl, 30 mM imidazole and 5 % glycerol, pH 7.5), and the protein was eluted with elution buffer (50 mM Hepes, 500 mM NaCl, 250 mM imidazole and 5 % glycerol, pH 7.5). EDTA (1 mM), 1 mM DTT (dithiothreitol), 2.5 mM CaCl 2 and thrombin (1 μg/mg of protein being cleaved) (Sigma catalogue number T6884-1KU) were added to the eluted protein, which was then injected into Slide-A-Lyzer Dialysis Cassettes [Pierce catalogue number 66110, 3500 MWCO (molecular-mass cutoff)]. Dialysis was carried out in 10 mM Hepes, 500 mM NaCl and 2.5 mM CaCl 2 , pH 7.5, overnight at 4
• C. After dialysis, the protein was loaded on a Ni-NTA Superflow column preequilibrated with binding buffer. The flow-through was dialysed in 10 mM Hepes, 500 mM NaCl (pH 7.5) for 2×45 min at 4
• C. Protein concentration was then carried out by centrifugation using Amicon Ultra-15 Centrifugal Filter Devices (Millipore; catalogue number UFC-901024; 10 000 MWCO), and the concentration of protein was determined by measuring A 280 using Cary 50 Bio UVVisible Spectrophotometer (Varian). Protein mass and purity was verified by MS (Agilent Technologies) and SDS/PAGE analysis. same for all wells at 0.4 mg/ml. Ligand binding was detected by monitoring the increase in thermostability of proteins in the presence of ligands. Protein thermostability at pH 7.5 was studied using StarGazer technology, which monitors protein stability by its aggregation properties. Protein samples were heated from 27 to 80
• C at a rate of 1 • C/min in clear-bottom 384-well plates in 50 μl of 100 mM Hepes (pH 7.5) and 150 mM NaCl. Protein aggregation was monitored by capturing images of scattered light every 30 s with a CCD (charge-coupled device) camera. The pixel intensities in a pre-selected region of each well were integrated to generate a value representative of the total amount of scattered light in that region. These total intensities were then plotted against temperature for each sample well and fit to the Boltzman equation by non-linear regression. The point of inflection of each 'denaturation' curve was identified as T agg . Change in stability of a protein is shown as T agg .
Isothermal denaturation
ITD (isothermal denaturation) measurements were performed in parallel at 37
• C in 384-well plates using a fluorescence plate reader (FluoDia T70, Photon Technology International), with excitation at 465 nm and emission at 590 nm [52] . The measurement for each protein was repeated six times within the plate. All the fluorescence measurements were performed in 20 μl of 0.1 M Hepes buffer, pH 7.5, containing 0.15 M NaCl, 5 times the final concentration of Sypro ® Orange and 0.1 mg/ml of protein. The target temperature of 37
• C was reached 60 s after the plate had been placed in the instrument and the software started. Fluorescence data points were collected every 60 s for 2-4 h. The ITD curves were fit to a double-exponential function of the form:
where k 1 and k 2 are two first-order rates of denaturation. In all cases, the rate constant k 1 was used to calculate the half lives (t 1/2 ) of the wild-type proteins and the SNPs.
Activity assays
Sulfotransferase activity assays
Enzyme assays were performed using a HPLC-based method previously described by Allali-Hassani et al. [53] . SULTs at 10-200 μg/ml were assayed in the presence of 0.1 mM PAPS and different concentrations of each substrate in 100 mM Hepes, pH 7.5, by incubating the reaction mixture at 37
• C for a period of time from 15 to 120 min depending on how quickly PAPS was converted into PAP (3 -phosphoadenosine 5 -phosphate). The K m values for characterized sulfotransferases are in the range of nanomolar to millimolar concentrations [35, 43] , with a significant variation in catalytic efficiency and substrate specificity. On the basis of these observations and considering possible substrate inhibition [36, 37] , we tested all sulfotransferases at substrate concentrations of 10, 25 and 100 μM. The reactions were stopped by adding 2 vol. of urea (final concn. 5.3 M), and the mixture was filtered through a 5-kDa MWCO Amicon Ultrafree-MC filter (Millipore, catalogue number MAUF01010) to remove the protein. The ratio of PAP and PAPS was determined after separating them on HPLC using a 4.5 mminternal diameter×50 mm-long WP QUAT, a strong ion-exchange column (J.T. Baker), using a gradient of triethylamine bicarbonate from 20 to 500 mM applied at 2 ml/min for 7 min. The progress of the reaction was monitored by reading the A 259 , and the amount of PAP produced was determined by integration of the resolved peaks using the HPLC software (Waters, http://www.waters. com/).
PK activity assays
Activity of the wild-type PK and its SNPs were assayed using a coupled reaction with lactic dehydrogenase [54] . Enzymatic reactions was started by adding 50 ng of enzyme (0.5 μg/ml) to 50 μl of reaction mixture [50 mM Hepes, pH 7.5, 50 mM KCl, 200 μM NADH, 20 mM MgCl 2 , 5 mM ADP, 7 units of lactic dehydrogenase and different concentrations of PEP (phosphoenolpyruvate; Sigma)]. The reaction progress was monitored for 3 min by following the decrease in A 340 using a Synergy 2 microplate reader from BioTek. In the absence of FBP, wild-type PKM2 exhibited classic Michaelis-Menten kinetics, possibly because the protein bound to bacterial FBP during expression in E. coli [50] . K m and V max values were obtained by fitting the data to a hyperbolic function using Sigma Plot 9.
Arginine methyltransferase assay
The arginine methyltransferase assay was performed using a coupled assay [55] . In this assay, SAHH (S-adenosylhomocysteine hydrolase) and adenosine deaminase convert the methyltransferase reaction product S-adenosylhomocysteine into homocysteine and inosine. Homocysteine can be quantified in the presence of ThioGlo 1 (exitation at 384 nm; emission at 513 nm). The substrate peptide used in this assay was the first 24 residues of histone 4 (SGRGKGGKGLGKGGAKRHRKVLRD). 
Fluorescence polarization
Fluorescence polarization assays were performed in 384-well plates, using the Synergy 2 microplate reader from BioTek. PFPKM2 peptide [GGAVDDD(PTyr)AQFANGG; where PTyr is phosphotyrosine] was synthesized, N-terminally labelled with fluorescein and purified by Tufts University Core Services (Boston, MA, U.S.A.). Binding assays were performed in a 10 μl volume at a constant labelled peptide concentration (30 nM), by titrating PKM2 and SNPs (at concentrations ranging from low to high micromolar) into 50 mM Hepes, pH 7.5, 50 mM KCl, 0.01 % Tween-20 and 1 mM DTT. A maximum fluorescence polarization of approx. 200-280 mP (milli-polarization level) was detected upon binding of PKM2 and its different SNPs to the labelled peptide, whereas typically approx. 90-100 mP was detected for free labelled peptide. To determine K d values, the data were fitted to a hyperbolic function using Sigma Plot software. (from 2 μM to 2 mM). Displacement of peptide was followed by a decrease in the FP signal. To determine the displacement constant (K displacement ), the data were fitted to a hyperbolic function using Sigma Plot software.
RESULTS AND DISCUSSION
As a result of recent improvements in high-throughput genotyping technologies, allele frequency for tens of thousands of SNPs have been made available [7] . Many variants have been identified that affect human physiology through genome-wide association studies using large cohorts. We selected 16 human enzymes with known biochemical activities and 3D structures in order to assess the frequency and mechanism by which SNPs affect the biochemical function of the proteins. For each protein target, all the SNPs with allele frequencies > 5 % in at least one ethnic population were selected (19 SNPs in total), as well as 37 additional lower-frequency alleles for a total of 56 SNPs. Importantly, prior literature knowledge or medical relevance was not a factor in selecting these SNPs. We subcloned the recombinant SNPs, which included 26 variants of eight different SULTs, 21 variants of PKM2 and nine variants of seven additional enzymes [INMT (indolethylamine N-methyltransferase), HRMT1L3 (human arginine methyltransferase 1-like protein), SRM (spermidine synthase), SIRT5, GAMT (guanidinoacetate N-methyltransferase isoform b), ARF4 (ADP-ribosylation factor 4) and PPIC (peptidylprolyl isomerase C)]. A total of 46 of these SNPs as well as their 'wild-type' proteins were purified to > 95 % purity and analysed for thermal stability using DSLS (Table 1) [ [27] [28] [29] 34] . Ten SNPs could not be sufficiently purified under the same conditions as the wild-type protein, owing to poor expression levels, aggregation and/or precipitation, suggesting that these proteins may be unstable relative to the wild-type protein (Table 1) .
Many common nsSNPs encode proteins with altered stability
The stability of almost half (48 %) of the purified variants was different from the respective wild-type protein, with 16 variants being less stable and six being more stable than their wild-type proteins ( Figure 1 and Table 1 ). A change in midpoint of the DSLS melting curve ( T agg ) of 2 • C was considered significant, with changes in stability as large as 11
• C. The results for the proteins that exhibited a change in stability by DSLS were confirmed using CD (results not shown). Overall, the stability of almost half of the SNPs was altered, with 35 % significantly less, and 13 % significantly more, stable ( Figure 1 ). If we consider the ten SNPs that could not be purified, the total fraction of SNPs with altered stability may be even greater. The magnitudes of the changes in stability were not related to the frequency of the SNP alleles, or to the enzyme class to which they belonged.
Predictive computational analysis of human SNPs also suggests that a change in protein stability is the major effect of nsSNPs [12, 13, 15, 16] . In view of the many thousands of nsSNPs in the human population, it is important to develop computational methods for assessing in vivo impact. Although such methods will not substitute for thorough experimental study, the analyses should be useful for obtaining a statistical picture of the extent to which these SNPs influence phenotype and for prioritizing SNPs for experimental study. Comparison of the current experimental results (Table 1) with two computational methods of SNP analysis [12, 13] (http://www.snps3d.org), serves as a bona fide test of the computational methods. Such a comparison ( Figure 2 and Table 1 ), using a two-degree threshold, shows that all but one of the six cases where both methods predict a stability impact and all but one of the 15 cases where both methods predict nondeleterious impact are correct. However, there are a number of cases where the predictions from the two methods differ. Thus, on this small sample, when the two computational methods agree, prediction accuracy is high [13] .
Altered protein stability changes the half-life of unfolding
Association of loss of in vivo activity due to SNPs with protein destabilization has previously been reported [12, [56] [57] [58] . In order to test if the change in stability of SNPs could affect the half-life of unfolding, we employed isothermal denaturation at 37
• C to measure the half-lives of those SNPs with altered stabilities [28, 52] . The half-lives of all tested mutants were altered and the changes correlated with the thermostability for tested variants ( Figure 3 , Table 1 ). Furthermore, it is also possible that a variant without a significant difference in T agg or T m may also have a different halflife at 37
• C relative to wild-type [29, 52] . This suggests that, at physiological temperatures, these and possibly some other SNPs may have lower functional levels. To investigate the effect that a decrease in protein half-life has on the level of enzyme activity The distribution of T agg , the difference between the T agg of each SNP and its wild-type counterpart ( T agg = T agg SNP−T agg wt), for 46 nsSNPs is plotted; the corresponding Pie chart shows the distribution of the effect. White areas indicate that the difference between T agg of the SNP and its wild-type is not significant (< 2 • C). Negative and positive values indicate destabilization and stabilization effects of SNPs respectively. Proteins are arranged from the most destabilized (largest negative T agg value) to the most stabilized (largest positive T agg value).
Figure 2 Comparison between experimental results and predicted effects of nsSNPs
Experimentally determined T agg values are plotted against scores assigned by sequence (᭹)-and structure (᭺)-based predictive methods [13] . Any change in T agg below 2 • C is considered within experimental error. For the computational methods, a positive score indicates a variant classified as not having a significantly deleterious effect on protein function in vivo, and a negative score indicates a variant with a deleterious effect. The larger the value, the more confident the assignment is. Benchmarking has shown accuracy to be significantly higher for scores > |0.5|. Computational scores and T agg values are shown in Table 1 .
over time, we monitored the activity of the wild-type PKM2 and PKM2_E28K after incubation at 37
• C from 2 to 33 min. Our results indicated that the activity of PKM2_E28K sharply decreases during the first 2 min of incubation (up to 40 %), and is almost inactive after the first 10 min. In contrast, the wild-type protein retained more than 80 % of its activity after 2 min of incubation and was still partially active (> 20 %) even after 33 min of incubation. Thus a change in stability of the SNPs may translate to a decrease in effective enzyme activity in vivo (see Supplementary Figure S2 at http://www.BiochemJ.org/bj/424/bj4240015add.htm). SNPs with lower stability can also result in insoluble aggregates that are prominent markers of aging and associated with cellular degeneration in many age-related diseases [56, 59] . Although the effects of these mutations might be buffered in the cell [56] , it is also possible that these variants may be subtle modifiers of normal physiology and disease.
Catalytic activity of variants
In order to assess the extent to which SNPs affect the catalytic activity of enzymes, we performed detailed enzymatic analysis on several enzyme variants, including those that did not display reduced thermal stability (Tables 2 and 3 ). Although a decrease in protein stability was in many cases associated with loss of activity (Figure 4 ), we observed cases in which thermally destabilized variants did not show altered activity, as well as cases in which the variant had altered catalytic activity, but no observable difference in stability. As discussed in the next section, these results can most often be explained through examination of the 3D protein structure.
PKM2 is a spliced isoform of PK that is expressed primarily in proliferating tissues and in cancer cells. Binding of FBP to PKM2 increases the catalytic efficiency of the enzyme allosterically by promoting the formation of the active tetramer [48] . Recently, it was reported that a phosphorylated tyrosine-containing peptide can bind to PKM2 and result in dissociation of FBP from the allosteric site, which reduces the activity of the enzyme. It was suggested that the concentration of FBP would be a determining factor in re-activating PKM2 to produce more energy [50] . Kinetic parameters were determined for wild-type PKM2 and all its variants (Table 2) . Seven PKM2 variants showed more than a 40 % decrease in activity. Significant increases in K m for PEP were observed for five variants, including S437Y, T45I and V71G, with 5-, 9-and 15-fold increase respectively. The presence of 1 mM FBP significantly decreased the K m value and consequently increased the catalytic efficiency of V71G, T45I, C31F and V292L by 12-, 6-, 3-and 2-fold respectively. S437Y was less sensitive to FBP binding, consistent with the location of Ser 437 in the FBP-binding pocket. All 16 PKM2 SNPs bound to the phosphotyrosine peptide that was previously reported to decrease the activity of PKM2 by causing FBP dissociation. This effect is expected to be overcome at high FBP concentration, leading to recovery of full enzymatic activity. Although the K d values for phosphotyrosine peptide binding were similar for all these SNPs, interestingly the presence of high concentrations of FBP resulted in peptide dissociation from the wild-type protein and all SNPs except for S437Y and E28K. This indicates that the level of PKM2 activity cannot be fine-tuned by relative concentrations of FBP and phosphotyrosine peptide in these two variants. The S437Y and E28K variants appear to disrupt the communication between the FBP and phosphotyrosine peptide binding sites. For S437Y, this effect may be due to an altered ability to bind FBP, because S437 is predicted to hydrogen-bond with FBP in the allosteric site of PKM2 ( Figure 5 ).
Table 2 Kinetic analysis of PKM2 SNPs
The enzymes were assayed as described in the Materials and methods section. K d peptide is the K d for phosphotyrosine peptide [50] , K displacement is the rate of phosphotyrosine peptide displacement by FBP. Kinetic parameters were calculated using SigmaPlot 9. K m values are determined for PEP. Catalytic efficiency is the ratio of K cat /K m . ND, no displacement was detected.
Figure 3 Half-lives of SNPs and wild-type proteins
Half-lives of some SNPs that showed stability different from that of their wild-type protein ( 2 • C) were determined at 37 • C using isothermal denaturation as described in the Materials and methods section. Values are the average of six measurements. Wild-type (WT) proteins are shown as white bars.
The human cytosolic sulfotransferases comprise a family of 12 phase II enzymes involved in the metabolism of drugs and hormones, the bioactivation of carcinogens and the detoxification of xenobiotics [37, 60] . Phenotypic changes in drug metabolism due to SNPs in SULTs contribute to inter-individual differences in drug sensitivity and are a well-studied area of pharmacogenomics [61, 62] . Enzymatic activity of SULT variants were assayed using selected substrates [38] . No significant (> 50 %) change in overall activities of SULT variants were observed, except for SULT1A3_T242P, which showed higher activity compared with its wild-type counterpart (Table 3) . Detailed kinetic analysis showed that the K m values of SULT1A3_T242P for substrates such as dopamine, isoprenaline and tyramine increased by 7-, 5-and 21-fold respectively. The V max values for these compounds were 4-5 times higher than that of the wild-type protein. In the present study we report that SULT1C1_Y128H, SULT4A1_I108M and SULT2A1_A261T are destabilized by 10.3, 2.2 and 2
• C respectively, relative to their wild-type counterparts. Although we did not see any significant changes in the activities of these proteins, their half-lives were reduced, raising the possibility that, under physiological conditions, these variants may be functionally impaired.
Two variants of HRMT1L3 were also significantly less stable than the wild-type enzyme, and their catalytic efficiencies were slightly lower than their wild-type counterpart (Table 3) . Protein arginine methyltransferase has been reported to play an important role in transcriptional regulation by methylation of histone H4 at Arg 3 [63] . A change in protein levels or activity of HRMT1L3 may Table 2 .
therefore have an epigenetic effect. The SIRT5 variant F285L, which was as stable as the wild-type SIRT5, was completely inactive (Table 3) .
Structural analysis of variants
We examined the protein structural effects for each SNP reported here ( Table 1 ). The majority of destabilizing mutations can be linked to disruption of the packing of buried residues in the core of the protein or to elimination of one or more hydrogen bonds.
Here we will focus mainly on the structural explanation of protein stability and activity for two well-studied enzyme classes, SULTs and PKM2, in which our data reveal novel SNP activities. PKM2 variants with altered stability or activity can be grouped into three categories; polymorphisms affecting buried residues, surface residues and those involved in binding sites or subunit interactions. Buried residues can affect catalytic efficiency for diverse reasons: Val 71 and Thr 45 are deeply buried in the hydrophobic core of PKM2 ( Figure 5 ). Though V71G does not create steric clashes and T45I may be accommodated by local adjustment of neighbouring side-chains, both mutants have a dramatically lower affinity for PEP, suggesting that altered hydrophobic packing may destabilize the overall structure, thereby affecting PEP binding (Table 2) . Interestingly, PEP affinity is rescued to near wild-type levels in the presence of 1 mM FBP, which indicates that FBP stabilizes the active conformation of the mutants. Another interesting buried residue is Gln 310 , which is located on a helix inserted into the groove of another PKM2 subunit ( Figure 5 ) and makes polar interactions with Arg 294 , a residue lining the catalytic site. Q310P is expected to break the helical topology, affect the quaternary arrangement of the tetramer, disrupt the interaction with Arg 294 , and induce conformational rearrangements at the active site ( Figure 5 ). This is in agreement with the loss of 90 % of the catalytic efficiency experimentally observed (Table 2) . Val 292 is a buried residue located next to Ala 293 , which directly lines the catalytic pocket ( Figure 5 ). The V292L mutant introduces a local steric strain that is likely to propagate to the active site, which would corroborate with the decreased affinity for PEP and lower activity. Some buried SNPs do not affect the catalytic activity of the enzyme: Val 490 is buried in the vicinity of the FBP-binding site and is less stable than wild-type PKM2. However, the fact that the V490L conservative mutation hardly affects the catalytic efficiency or FBP's ability to displace the phosphorylated peptide strongly suggests that neighbouring residues can accommodate a leucine residue at position 490. Glu 275 is a surface residue surrounded with lysine and arginine residues, and stability or activity of E275D variant would not have been predicted to be different from that of wild-type PKM2. The observed decrease in stability and approx. 2-fold loss in catalytic efficiency may be attributable to a mild local rearrangement necessary to accommodate the shorter aspartate side chain, which may propagate to neighbouring Glu 272 , a residue that co-ordinates a catalytic Mg 2+ in the crystal structure of rabbit PK (PDB code 1a49). This is an example which indicates that preservation of physico-chemical properties at the site of mutation does not always result in small effects [64] .
Since PKM2 is known to be regulated via quaternary structural allosteric mechanisms [48, 65] , residues located at the interface of two PKM2 subunits may induce non-native quaternary motions that could affect catalytic activity. Arg 339 is located at the exit of a loop that lines the catalytic site and is at the interface with another PKM2 subunit. The R339P mutation may induce quaternary restraints that directly propagate along the loop into the catalytic site, thereby critically affecting the catalytic activity of the enzyme. Cys 31 is remote both from the catalytic site and the allosteric activation site. It is located at the interface with another PKM2 subunit, and the C31F mutant may destabilize the quaternary arrangement of PKM2, which could explain the observed decrease in affinity for PEP (Table 2 ). This destabilization is probably not strong, since 1 mM FBP can almost fully revert to wild-type catalytic efficiency.
The E28K variant of PKM2 is intriguing. Glu 28 is at the interface of two PKM2 monomers and makes electrostatic interactions with Arg 319 in a neighbouring subunit ( Figure 6 ). Glu 28 is over 30 Å (1 Å = 0.1 nm) away from the closest FBP-binding site, and over 25 Å away from the closest catalytic site. Nevertheless, the E28K variant is reduced in its catalytic efficiency by 75 % with no addition of FBP and even by 37 % in the presence of 1 mM FBP. Moreover, unlike the wild-type enzyme, FBP, which results in a 2.5-fold gain in catalytic efficiency, is unable to displace a phosphotyrosine peptide in the E28K mutant, even though the peptide affinity is unchanged. This suggests that the E28K mutation affects allosteric regulation of PKM2 activity, possibly by affecting FBP binding. On the other hand, the S437Y mutant directly affects FBP binding ( Figure 5 ). Ser 437 lines the FBPbinding site and the hydroxy group of Ser 437 is hydrogen-bonded to FBP. S437Y is predicted to preclude FBP binding, and thus prevent stabilization of the PKM2 active form. This is consistent with the observed inability of FBP to displace a phosphotyrosine peptide and with the dramatically reduced affinity of the protein for PEP. For S437Y, this is clearly related to the involvement of Ser 437 in hydrogen-bonding with FBP in the allosteric site of PKM2 [65, 66] . Genetic variations in PKM2 that results in a change in level of activity and allosteric properties of PKM2 may alter the susceptibility to cancer as well as affecting embryonic development.
Our SNP data reported here also reveal changes in activity and stability for several of the SULTs. SULT1C1_Y128H was dramatically destabilized, probably due to the elimination of a buried hydrogen bond with His 176 , which in turn contributes to the packing of helix 7 on to the central β-sheet. The observed change in specificity of SULT1A3_T242P can also be explained through structural analysis. Thr 242 is in one of the flexible loops, part of which contributes to the catalytic site of this enzyme [38] . Thus our data for this SNP suggests that a rigid proline residue Phe 254 is buried in the core of the INMT structure (PDB code 2a14) and fully occupies the cavity generated by surrounding residues (A, magenta mesh). A cysteine residue makes reduced Van der Waals contacts, which may result in decreased stability (B).
at this position may favour a change in conformation of the loop, resulting in a change in catalytic activity and that individuals with this SNP may metabolize substrates at high concentrations more efficiently.
Other variants
Three of the SNPs with increased stability had conservative mutations of one hydrophobic residue for another at buried positions within the protein core ( Table 1 ). The greater stability of these SNPs may therefore be the result of improved sidechain packing within the core of the protein. INMT_F254C and ARF4_V68A are both significantly destabilized and can be classified as mutations in which a large hydrophobic residue buried in the interior of the protein is changed to a smaller hydrophobic residue (see, for example, Figure 7 ). The creation of 'void volumes' in the interior of proteins comes at a high energetic cost. For example, studies on ''large-to-small' substitutions in the hydrophobic core of T4-lysozyme and barnase resulted in mutants that were destabilized by several kcal/mol (1 cal ≈ 4.184 J) [67] [68] [69] . ARF4 specifically recognizes the C-terminal sorting signal of rhodopsin, regulating its incorporation into specialized post-Golgi rhodopsin transport carriers targeted to the rod outer segments of retinal photoreceptors [70] . Rhodopsin C-terminal mutants that affect its interaction with ARF4 contribute to the pathology of retinitis pigmentosum, raising the possibility that the ARF4_V68A variant might be a disease-modifying allele. INMT catalyses the production of bufotenine and N,N-dimethyltryptamine, which are hallucinogenic dimethylated indolethylamines, from serotonin and tryptamine. A change in cellular availability of this enzyme might contribute to the pathology of schizophrenia or other psychiatric illnesses [71] .
Concluding remarks
In conclusion, our studies have focused on exploring the possibility that relatively common non-synonymous protein variants might display altered thermal stability or catalytic activity. Although we were only able to test a small number of human proteins for pragmatic reasons, we observed that a remarkably large number showed altered stability and function. Although the effects of these mutations might be buffered in the cell, it is also possible that some of these alleles may be subtle modifiers of normal physiology and disease.
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